David Flowers
Publications by Year
Research Areas
Monoclonal and Polyclonal Antibodies Research, Cancer Immunotherapy and Biomarkers, CAR-T cell therapy research, Cardiac electrophysiology and arrhythmias, Cardiac Arrhythmias and Treatments
Most-Cited Works
- → Pluripotent, cytokine-dependent, hematopoietic stem cells are immortalized by constitutive Notch1 signaling(2000)635 cited
- → Gemtuzumab Ozogamicin, A Potent and Selective Anti-CD33 Antibody−Calicheamicin Conjugate for Treatment of Acute Myeloid Leukemia(2001)583 cited
- → Selective Ablation of Acute Myeloid Leukemia Using Antibody-Targeted Chemotherapy: A Phase I Study of an Anti-CD33 Calicheamicin Immunoconjugate(1999)456 cited
- → The Notch Ligand, Jagged-1, Influences the Development of Primitive Hematopoietic Precursor Cells(1998)325 cited
- → Immobilization of Notch ligand, Delta-1, is required for induction of Notch signaling(2000)311 cited
- → An Anti-CD33 Antibody−Calicheamicin Conjugate for Treatment of Acute Myeloid Leukemia. Choice of Linker(2001)226 cited
- → Wild-type microglia do not reverse pathology in mouse models of Rett syndrome(2015)201 cited
- → Multidrug-resistance phenotype and clinical responses to gemtuzumab ozogamicin(2001)199 cited
- → CD33 expression and P-glycoprotein–mediated drug efflux inversely correlate and predict clinical outcome in patients with acute myeloid leukemia treated with gemtuzumab ozogamicin monotherapy(2007)191 cited